Company Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.
The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services.
This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise.
In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software.
The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments.
It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 1999 |
| IPO Date | Nov 18, 1999 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 18,100 |
| CEO | Padraig McDonnell |
Contact Details
Address: 5301 Stevens Creek Boulevard Santa Clara, California 95051 United States | |
| Phone | 800 227 9770 |
| Website | agilent.com |
Stock Details
| Ticker Symbol | A |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0001090872 |
| CUSIP Number | 00846U101 |
| ISIN Number | US00846U1016 |
| Employer ID | 77-0518772 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Padraig McDonnell | Chief Executive Officer, President and Director |
| Rodney Gonsalves | Vice President, Corporate Controller and Principal Accounting Officer |
| Bret M. DiMarco | Senior Vice President, Chief Legal Officer, and Secretary |
| Angelica A. Riemann | Senior Vice President and President of Agilent CrossLab Group |
| Dr. Simon May | Senior Vice President and President of Life Sciences and Diagnostics Markets Group |
| Adam S. Elinoff | Senior Vice President, Chief Financial Officer and Principal Financial Officer |
| August Specht Ph.D. | Senior Vice President and Chief Technology Officer |
| Tejas Rajeev Savant | Vice President of Investor Relations |
| Frederick Schwarz | Senior Vice President, Chief Strategy and Corporate Development Officer |
| Meghan A. Henson | Senior Vice President and Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2026 | 8-K | Current Report |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 20, 2026 | 8-K | Current Report |
| Mar 6, 2026 | 8-K | Current Report |
| Mar 3, 2026 | 10-Q | Quarterly Report |
| Feb 25, 2026 | 8-K | Current Report |
| Feb 6, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 6, 2026 | ARS | Filing |
| Feb 6, 2026 | DEF 14A | Other definitive proxy statements |
| Jan 23, 2026 | PRE 14A | Other preliminary proxy statements |